Related Experiment Video
Updated: Mar 8, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.7K
Summary
The National Cancer Institute (NCI) Formulary provides faster access to cancer drugs for research. This program supports investigators at NCI-designated cancer centers for preclinical and clinical studies.
Area of Science:
- Oncology
- Drug Development
- Clinical Trials
Background:
- The National Cancer Institute (NCI) operates the Cancer Therapy Evaluation Program.
- Collaboration with pharmaceutical companies is crucial for advancing cancer research.
Purpose of the Study:
- To launch the NCI Formulary, a collaborative initiative.
- To expedite access to investigational cancer drugs for researchers.
Main Methods:
- Partnering with pharmaceutical companies.
- Establishing a centralized drug formulary.
Main Results:
- Facilitating access to drugs for preclinical studies.
- Enabling access to drugs for clinical studies.
Conclusions:
- The NCI Formulary accelerates drug availability for cancer research.
- Supports investigators at NCI-designated cancer centers.
